Company / Cash per Share
Terns Pharmaceuticals, Inc. Cash per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$2.03
FY2024
5-year range
$1.12 / $262.50
FY2020-FY2024
Trend
+81.0%
vs FY2023
Sector context
#102 of 203
Health Care
What the data says
At $2.03, Terns Pharmaceuticals, Inc.'s cash per share ranks #102 of 203 in the Health Care sector. Cash per Share has fluctuated over the past 5 years, ranging from $1.12 in FY2023 to $262.50 in FY2020.
Based on SEC 10-K filings.
2.03 in FY2024 with a 3-year CAGR of -1.1%.
Declined from $3.98 to $2.03 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -1.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#102 of 203 in Health CareTop 50% of 203This company $2.03 Sector average $76.43
▼
-97.3% below sector average
Key checks
Key Insights
- In FY2024, cash per share increased 81.0% year-over-year.
- Ranks #102 out of 203 companies in the Health Care sector.
- Peak cash per share was recorded in FY2020.
- Lowest cash per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 7.86 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $2.03 | +81.0% |
| FY2023 | $1.12 | -71.8% |
| FY2022 | $3.98 | +89.2% |
| FY2021 | $2.10 | -99.2% |
| FY2020 | $262.50 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026